review on glp-1 agonists and psychiatric effects Safety of Receptor Across Type 2 Diabetes Obesity: An Integrative Association between GLP-1 receptor agonist

Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database

In a recent study, it was revealed that in the ischemic stroke model in C57 mice, the intervention of allicin has the potential to decrease areas of cerebral infarction (167)

Harte SE, Clauw DJ, Napadow V, Harris RE

At the molecular level, the research proposes that GHK-Cu may interact with the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) signaling pathway

Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL

Our holistic approach ensures that each patient receives an integrated treatment experience, suitable for various stages of recovery